ACCPNephroPRN
@ACCPNephro
Followers
185
Following
103
Media
24
Statuses
166
The American College of Clinical Pharmacy's Nephrology PRN is a collegial network of pharmacists that practice in acute and chronic care of kidney disease
Joined October 2016
International consensus on post-transplantation diabetes mellitus 🔓 https://t.co/dsWfZ5Vmpv
0
51
117
We are excited to share that the KDIGO Blood Pressure in CKD Guideline is now digitally available for FREE in Acumen Epic Connect via @AvoMD, allowing you to save time and standardize evidence-based care! Get started by reaching out to info@avomd.io. #Nephrology #CKD #BP
2
11
42
We are excited to share that we have added five new modules to our curriculum! Register today at: https://t.co/V8xo4JnHWx
0
0
2
Check out the May issue of KDIGO Direct for the latest news and updates from KDIGO: https://t.co/j7xtQhdK2t. In this issue: International Consensus Statement on Standardized Blood Pressure Measurement, the KDIGO Home Dialysis Controversies Conference Report, the 2023 ANCA
0
9
32
📣 Join us tomorrow for our monthly journal club by some awesome PGY-2 Pharmacotherapy and Internal Medicine Residents! Zoom link can be found in your email #AMEDPRN @HFHPharmRes @RxCutshall @candradhubbard @MUHPharmRes @dukerxresidency
1
5
12
Our new curriculum is LIVE. 🎉 If you want to learn more about Slowing Kidney Disease Progression, enroll at the link in our bio. #TwitteRX #pharmacists #AKHOMM #NephTwitter #kidneycare #PharmacyUMN #GetTheMedicationRight #nephrologist #nephrologynurse #nursepractitioner
1
9
11
KDIGO is pleased to announce the publication of the Home Dialysis Controversies Conference Report in the May 2023 issue of @Kidney_Int. The conference was co-chaired by @PD_Perls and @wilkiemart. Read the news release: https://t.co/36cToLk7dn Download the conference report:
1
52
112
🗓 SAVE THE DATE! We are partnering with @ACCPNephro to co-host a webinar, Removing Race from the eGFR Calculation. Presented by @WendyStPeter002 and moderated by @JayCdoesID on April 19th via Zoom. Register here: https://t.co/FJlDLtjBOr
@RenaGosser @rx_phan
0
8
15
The magic of evolving in #criticalcare is appreciating where your patient is on the curve and determining what that means, add add add, hold up, or put Humpty Dumpty back together. Being mindful of the creatinine blind period is as important in deterioration as recovery!
Patients with AKI experience multiple pharmacokinetic and pharmacodynamic perturbations that dynamically influence medication effectiveness and safety. This article discusses optimal medication management for patients with AKI https://t.co/vdYpYkYNNf
@AFlanneryPharmD
2
9
19
Includes a nice review of clinical trials too! And of course, #pharmacists can play 🔑 roles in supporting #adherence (*cough*pseudoresistance*cough* 😉) and best medication use practices!
🚨NEW Review: Resistant hypertension in dialysis 📖 https://t.co/O31k9U8TVz 📸Proposed work-up of dialysed patients with apparent treatment-resistant hypertension
0
0
3
Meet the team that’s accelerating the implementation of comprehensive medication management services for those with kidney disease in the U.S. #TwitteRX #pharmacists #AKHOMM #NephTwitter
0
2
4
KDIGO is pleased to announce the formal launch of an update to its 2012 Acute Kidney Injury (#AKI) Guideline. Matthew James (Canada) and @MarliesOsterman (United Kingdom) will co-chair the guideline update. Read the full News Release: https://t.co/LeOT7HK7xl
4
86
272
Vancomycin 5–7.5 mg/kg q12h is recommended as the initial dosage regimens for ICU patients undergoing CRRT. https://t.co/K4bU7uj0SD
@accpinfdprn
4
37
142
These accurate models could assist clinicians in predicting tacrolimus efficacy in pediatric patients with nephrotic syndrome before utilization to avoid treatment failure or adverse effects. https://t.co/Li3Duhuvb9
@accppediprn @ACCPNephro
0
2
6
Dose optimization utilizing TDM early in cefepime treatment may minimize adverse effects and improve patient safety. https://t.co/5NnEIBobrD
@Veena_PharmD @accpinfdprn @ACCPNephro
0
14
54
#TwitteRx -- what are YOU wanting to 👀 in future @ACCP #NephPRN CE sessions? Tell us in a 1-minute, one question survey! 👇 https://t.co/8QjbHHbRT7
0
2
2
KDIGO is pleased to announce the publication of the 2022 Diabetes Management in CKD Guideline. Read the Guideline: https://t.co/A6LdZbr3qg Read the Executive Summary: https://t.co/vnt32SGix3 Read the News Release: https://t.co/LMc8JRFyM2
#diabetes #CKD
6
332
640
So great being back in-person for #ACCPGC22! What is the #NephPRN 👀 today?? - @accpendoprn Focus Session on #CKD and #SGLT2i @ 1:15-2:45 PM - Best Practices for Caring for Patients on Race and Genetic Modifiers for Medication Management @ 3:00-4:30 PM
0
0
0